Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NAD/Carnation

This article was originally published in The Tan Sheet

Executive Summary

Nestle's failure to discontinue ad claims stating Carnation Good Start infant formula is easier to digest, more similar to breast milk than other formulas warrants FTC referral, National Advertising Division of the Council of Better Business Bureaus says in recently released Case Report. NAD deemed claims unsubstantiated in response to Similac marketer Abbott Lab's challenge last year (1"The Tan Sheet" Feb. 12, 2001, p. 20). In separate case involving a J&J/Merck challenge for Novartis' claims that Maalox Quick Dissolve neutralizes more acid and dissolves faster than Pepcid Complete, NAD says it has closed the case since Novartis discontinued disputed ads permanently...
Advertisement

Related Content

Nestle Carnation Good Start Infant Formula "Comfort Proteins" Unique - NAD
Nestle Carnation Good Start Infant Formula "Comfort Proteins" Unique - NAD

Topics

Advertisement
UsernamePublicRestriction

Register

PS093525

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel